This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Natco Pharma Limited. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Sreenivas Nagapuri: Innovator in Pharmaceutical Intermediates
Introduction
Sreenivas Nagapuri is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel intermediates for drug preparation. His work is characterized by a focus on commercially viable processes that can be scaled for industrial applications.
Latest Patents
Sreenivas holds 1 patent for his invention titled "Intermediates for the preparation of eribulin thereof." This patent relates to novel intermediates of Eribulin and outlines a process for their preparation. The process described in the patent is not only innovative but also commercially viable, making it suitable for plant-scale operations. The invention focuses on tetrahydrofuran compounds of specific formulas, which are crucial for the synthesis of Eribulin.
Career Highlights
Sreenivas Nagapuri is currently associated with Natco Pharma Limited, a prominent player in the pharmaceutical industry. His role at the company allows him to apply his expertise in drug development and contribute to the advancement of pharmaceutical sciences. His work has implications for improving the efficiency and effectiveness of drug manufacturing processes.
Collaborations
Sreenivas has collaborated with several professionals in his field, including Bulli Babi Vipparla and Sathaiah Kandula. These collaborations have likely enhanced the scope and impact of his research and innovations.
Conclusion
Sreenivas Nagapuri is a distinguished inventor whose work in pharmaceutical intermediates has the potential to influence drug manufacturing significantly. His innovative approach and dedication to developing scalable processes mark him as a valuable contributor to the field.